Implements maximum likelihood methods for
evaluating the durability of vaccine efficacy in a randomized,
placebo-controlled clinical trial with staggered enrollment of participants
and potential crossover of placebo recipients before the end of the trial.
Lin, D. Y., Zeng, D., and Gilbert, P. B. (2021)